Treatment guideline policies
The following policies are only available on the Gloucestershire Hospitals NHS Foundation Trust IT network.
- A0062: Opioid Users on the Ward - Management Guidelines Policy
- A0357: Blood Ketone Testing for Suspected Diabetes Ketoacidosis (Adults) Policy
- A0132: Diabetes in Adults - Before, During and After Surgery Policy
- A0232: Perioperative Steroid Supplementation (Adult) Policy
- A0193: Mouth Care Guidelines Policy
- A2112: Topical Morphine for Painful Wounds Policy
- A2050: Post Operative Care of Carotid Endarterectomy (CEA) Patients Policy
- A2165: Anticoagulants, Antiplatelets And Spinal/ Epidural Anaesthesia (Neuraxial anaesthesia) Policy
- A2046: Potassium Permanganate Application Policy
- A2036: Dithranol in Lassar's Paste for Psoriasis - Guidelines for Application Policy
- A0371: Intravenous Fluid Management in Adults Policy
- A2156: Tumour Lysis Syndrome Prevention And Management Policy
- A2034: Hypoglycaemia Adult Policy
- A0234: Meticillin Resistant Staphylococcus Aureus (MRSA) Policy
- A0089: Epilepsy and Status Epilepticus Management Policy
- A2145: Post Operative Nausea and Vomiting (PONV) Guidelines in Adults Policy
- A2137: Ketamine Guidelines Policy
- A0143: Emergency Sedation Policy
- A0311: Non-Invasive Ventilation for Acute Hypercapnic Respiratory Failure Policy
- A2095 WAR1: Warfarin Initiation Protocol Policy
- A0365: Thrombolysis for Massive Pulmonary Embolism Policy
If you have any difficulty accessing any of the above please contact the Pharmacy team.